We spoke to an ADHD author about "rejection sensitive dysphoria".
Despite decades of research, these ADHD myths still affect how people understand attention and behavior.
With everything there is to juggle in life, it’s easy to assume that everyone experiences that sinking-in-quicksand feeling as they navigate another busy day. But if you find this feeling is paired ...
Cambridge scientists have shown that problems regulating emotions – which can manifest as depression, anxiety and explosive outbursts – may be a core symptom of attention deficit hyperactivity ...
A therapist who has attention deficit hyperactivity disorder (ADHD) has gained viral attention after she shared a rarely talked about symptom of the condition. In a video with 1.3 million views, ...
GlobalData on MSN
FDA accepts Otsuka’s centanafadine application for ADHD treatment
The Prescription Drug User Fee Act target action date for the NDA is scheduled for 24 July 2026.
Attention-deficit/hyperactivity disorder (ADHD) medications appeared to reduce the risk for suicide, drug misuse, transport incidents, and criminal activity, a new ...
Findings showed statistically significant reductions in the ADHD Investigator Symptom Report Scale total score were seen with solriamfetol 150mg vs placebo at week 6. Topline data were announced from ...
This article was reviewed by Lynn Marie Morski, MD, JD. Key Takeaways: ADHD and menopause symptoms can overlap, and one condition might exacerbate the other. Fluctuating ...
Please provide your email address to receive an email when new articles are posted on . Those with three or more ADHD symptoms had the greatest odds for nicotine and tobacco use. The findings suggest ...
Centanafadine is a first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor designed to address the core symptoms of ADHD in children and adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results